Medindia LOGIN REGISTER
Medindia

Technique to Detect False Positive COVID-19 Results Discovered

by Colleen Fleiss on Nov 17 2021 10:04 PM

A process to identify potential false-positive COVID-19 results has been discovered. The method, used at MU Health Care, could help other laboratories prevent unnecessary quarantining and repeated testing of people who are not actually infected.

Technique to Detect False Positive COVID-19 Results Discovered
A process to identify potential false-positive COVID-19 results has been discovered by University of Missouri School of Medicine researchers.
The method, used at MU Health Care, could help other laboratories prevent unnecessary quarantining and repeated testing of people who are not actually infected.

But while this type of test is considered reliable, it is associated with a small number of false positive results, most easily recognized in asymptomatic, nonexposed patients.

“False positive diagnoses have important implications for patient management,” said Lester Layfield, MD, professor of pathology and anatomical sciences and director of the Molecular Diagnostics Laboratory. “False positives may lead to inappropriate quarantine, delay of other necessary medical treatment or transfer to a COVID-19 ward.”

To help ensure the accuracy of positive tests, Layfield developed a protocol for repeat testing of all positive results involving asymptomatic and unexposed patients, and in all cases in which a specimen with a positive result was located in a testing well next to another specimen with a high virus load.

Layfield and his team of researchers implemented the quality control protocol in September 2020. Over an eight-week period, 24,717 RT-PCR tests were performed. Of those, 6,251 came from asymptomatic patients. In that group, 288 specimens initially returned a positive result. A second test revealed 20 of these to be false positives.

Advertisement
“Retesting of positive results from asymptomatic individuals revealed some technologist errors but also contamination from positive specimens in adjacent specimen wells,” Layfield said. “This study should alert the laboratory testing community of the possibility of false positive COVID-19 tests.”

In addition to Layfield, the study authors include Douglas C Miller, MD, PhD, chair of pathology and anatomical sciences; resident physician Kelly Bowers, DO; and Simone Camp. The authors declare they have no conflict of interest to report in relation to this study.

Advertisement
Their study, “SARS-CoV-2 detection by reverse transcriptase polymerase chain reaction testing: Analysis of false positive results and recommendations for quality control measures,” was published in the Journal Pathology - Research and Practice.

Source-Eurekalert


Advertisement